SR-9009 (1379686-30-2) is an agonist at nuclear receptor Rev-ErbA.1 Greatly diminishes VILI-induced lung edema, inflammatory cell infiltration and TNFα production in a rat lung injury model.2 SR-9009 suppresses atherosclerosis in a mouse model.3 Specifically lethal to cancer cells and oncogene-induced senescent cells with no effect on the viability of normal cells or tissues.4 Disrupts pain associated with osteoarthritis by reducing BMAL1 expression in bmal1f/fNav1.8CreERT mice.5
1) Solt et al. (2012) Regulation of circadian behavior and metabolism by synthetic REV-ERB agonists; Nature, 485 62 2) Li et al. (2014) A study on circadian rhythm disorder of rat lung tissue caused by mechanical ventilation induced lung injury; Int.Immunopharmacol. 18 249 3) Sitaula et al. (2015) Suppression of atherosclerosis by synthetic REV-ERB agonist; Biochem. Biophys. Res. Commun.,460 566 4) Sulli et al. (2018) Pharmacological activation of REV-ERBs is lethal in cancer and oncogene-induced senescence; Nature, 553 351 5) Das et al. (2018) Pharmacological targeting of the mammalian clock reveals a novel analgesic for osteoarthritis-induced pain; Gene 655 1 Tricaine Methanesulfonate
Please note that we do not sell to individuals and that all orders placed by non-research organizations will incur a $20 restocking/refund fee. Materials provided by Focus Biomolecules are for laboratory research use only and are not intended for human or veterinary applications.
Materials provided by Focus Biomolecules are for laboratory research use only and are not intended for human or veterinary applications. Please note that we do not sell to individuals and that all orders placed by non-research organizations will incur a $20 restocking/refund fee
SR-9009 (1379686-30-2) is an agonist at nuclear receptor Rev-ErbA.1 Greatly diminishes VILI-induced lung edema, inflammatory cell infiltration and TNFα production in a rat lung injury model.2 SR-9009 suppresses atherosclerosis in a mouse model.3 Specifically lethal to cancer cells and oncogene-induced senescent cells with no effect on the viability of normal cells or tissues.4 Disrupts pain associated with osteoarthritis by reducing BMAL1 expression in bmal1f/fNav1.8CreERT mice.5
1) Solt et al. (2012) Regulation of circadian behavior and metabolism by synthetic REV-ERB agonists; Nature, 485 62 2) Li et al. (2014) A study on circadian rhythm disorder of rat lung tissue caused by mechanical ventilation induced lung injury; Int.Immunopharmacol. 18 249 3) Sitaula et al. (2015) Suppression of atherosclerosis by synthetic REV-ERB agonist; Biochem. Biophys. Res. Commun.,460 566 4) Sulli et al. (2018) Pharmacological activation of REV-ERBs is lethal in cancer and oncogene-induced senescence; Nature, 553 351 5) Das et al. (2018) Pharmacological targeting of the mammalian clock reveals a novel analgesic for osteoarthritis-induced pain; Gene 655 1
Stock concentration: molar (M) millimolar (mM) micromolar (μM) nanomolar (nM) picomolar (pM) femtomolar (fM) Desired final volume: liters (L) milliliters (mL) microliters (μl) Desired concentration: molar (M) millimolar (mM) micromolar (μM) nanomolar (nM) picomolar (pM) femtomolar (fM) Required volume: L
Calculate the molar concentration, mass or volume in a solution. Concentration × Volume × Molecular Weight = Mass Concentration femtomolar picomolar nanomolar micromolar millimolar molar Volume nanoliter microliter milliliter liter Molecular Weight daltons Mass picograms nanograms micrograms milligrams grams
Calculate the molar concentration, mass or volume in a solution.
Concentration × Volume × Molecular Weight = Mass
HGH Fragment 176-191 Website Created by Advanta Advertising LLC.